Floatz logo

ACETIC ACID, SODIUM SALT (1:1)

Gliomas

Phoenix Molecular ImagingSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gliomas cohort.

Asset / SponsorPhaseRating
Procarbazine
Martin-Luther-Universität Halle-Wittenberg
Phase 2CCC
Cilengitide
Martin-Luther-Universität Halle-Wittenberg
Phase 2CCC
ROSOPATAMAB
Weill Medical College of Cornell University
Phase 1CC
Alloreactive Ctl
Jonsson Comprehensive Cancer Center
Phase 1CC
Fluciclovine
M.D. Anderson Cancer Center
Early Phase 1C

Same molecule, other indications

ACETIC ACID, SODIUM SALT (1:1) is also rated in:

Stroke, AcuteDormant
B
Indicative ·
57 / 100
View asset →
Prostate AdenocarcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
Prostate CancerDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →